Original release date: May 31, 2019
Access to this course expires on: March 20, 2022 at 11:59 PM Pacific Time
Practicing academic and community pathologists, and pathologists-in-training
Upon completion of this educational activity, learners will be able to:
Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 6.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 6.5 SAM/Part II credit hours.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported no relevant financial relationships: Aleodor Andea, MD, MBA, Victor G. Prieto, MD, PhD, Steven D. Billings, MD, Francisco G. Bravo, MD, Thomas Brenn, MD, PhD, FRCPath, Jason L. Hornick, MD, PhD, Doina Ivan, MD, Elaine Jaffe, MD, Rajiv Patel, MD, Richard Scolyer, MBBS, MD, BMedSi, Michael Tetzlaff, MD, PhD, Carlos Torres-Cabala, MD, Iwei Yeh, MD, PhD
The following IM Coordinator who planned and reviewed content for this activity reported no relevant financial relationships: Steven D. Billings, MD
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME and SAM credit, all learners must complete the evaluation. Your certificate will be available to view and print by clicking here.
Buy the entire 2019 Annual Meeting Long Course and get a great discount!
Not A Member? Click Here
Dermatopathology is a relatively specialized area of pathology requiring additional training; however, skin specimens are commonly encountered in the general surgical pathology practice, frequently constituting a large proportion of the total number of biopsies signed by general surgical pathologists. Accurate diagnosis of these cases entails knowledge of the vast array of potential diagnoses as well as competence in recognizing the histologic clues, which are often subtle, and in integrating the clinical findings. For the practicing pathologist lacking subspecialized training in dermatopathology, diagnosing these specimens may present a daunting task, especially for the less common diseases. In addition, in our age of precision medicine, the information one needs to include in the pathology report often involves ancillary molecular testing. Molecular discoveries with applications in diagnosis, prognosis and management are reported regularly within the literature, and yet, the typical practicing pathologist cannot easily distill this information to that which will meaningfully aid in diagnosis and/ or impact patient care. To this end, the aim of this course is to present the audience with relatively common dermatopathologic lesions and a focus on those entities that create challenges in diagnosis and / or have significant clinical implications. The course will provide a practical approach to common issues encountered in dermatopathology. The audience will be presented with the salient features of each entity, a choice of relevant ancillary tests and tips to avoid misdiagnosis.